News | October 21, 2007

SAVI Breast Brachytherapy Reaches 100-Patient Milestone

October 22, 2007 - Cianna Medical recently announced that 100 patients have been treated with the SAVI applicator, a single-entry, multi-catheter applicator that delivers radiation therapy as part of breast conservation therapy.

By using a more precisely targeted dose of radiation, SAVI treats the tissue surrounding the lumpectomy cavity while minimizing radiation dose to healthy tissue. Instead of the six week course of treatment required by whole breast radiation, treatment with the SAVI applicator lasts just five days. This approach is becoming a more widely used alternative to whole breast irradiation, according to the manufacturer.

“SAVI is becoming a very important tool in the management of our breast cancer patients, because we can deliver breast brachytherapy to more patients than we could with its predecessor,” said Constantine Mantz, M.D., radiation oncologist with 21st Century Oncology.

“The great advantage of partial breast irradiation is that it expedites the course of radiation therapy that a woman would receive following surgery,” said Dr. Mantz. “Because SAVI is a multi-catheter device we can exert far greater control over how radiation is delivered in the breast. We have the luxury of being able to place the device very close to the skin or very close to the chest wall and still deliver a safe and effective treatment.”

Radiation treatment after a lumpectomy has traditionally involved irradiation of the entire breast with an external beam. This “whole breast irradiation” exposes more healthy tissue and involves a lengthy treatment course, with radiation delivered five times a week over a six-to-seven week period.

For more information: www.ciannamedical.com

Related Content

MR-HIFU, ThermoDox, combination therapy, recurrent childhood tumors, Celsion, Children's National Health System, Phase I clinical study
News | Oncology Related Products | December 19, 2016
December 19, 2016 — Children’s National Health System and Celsion Corp.
News | Clinical Decision Support | October 27, 2016
October 27, 2016 — The National Comprehensive Cancer Network (NCCN) continues to build its library of appropriate use
contrast-enhanced ultrasound, CEUS, liver cancer, hepatocellular carcinoma, study, Advances in Contrast Ultrasound conference, ICUS
News | Ultrasound Imaging | September 12, 2016
September 12, 2016 — Tiny microbubbles are being used to more effectively...
cardio-oncology, echo strain assessment, echoinsight, epsilon

Epsilon's EchoInsight software helps analyze cardiac function by evaluating wall motion strain. 

Feature | Cardio-oncology | May 13, 2016 | Dave Fornell
Cardio-oncology is an emerging field that combines the expertise of both cardiology and oncology to assess and treat
Carestream, Clinical Collaboration Platform, Fox Valley Hematology & Oncology
News | Enterprise Imaging | April 20, 2016
Fox Valley Hematology & Oncology (Appleton, Wis.) implemented Carestream’s Vue for Clinical Collaboration Platform...
cancer immunotherapy, development, Axel Hoos, Nature Reviews, imaging
News | Oncology Related Products | March 31, 2016
In a paper published in Nature Reviews last week, Axel Hoos, M.D., Ph.D., laid out the current immunotherapy...
Pyrexar, buy back outside ownership, Person Medical, BSD-2000 Hyperthermia System

BSD-2000 image courtesy of Pyrexar Medical

News | Oncology Related Products | March 15, 2016
Pyrexar announced it has purchased back outside ownership from Person Medical (formerly BSD Medical), concluding a...
BTG, LC Bead LUMI, radiopaque embolic bead, Philips Healthcare, Live Image Guidance, liver cancer
News | Interventional Radiology | February 09, 2016
BTG plc and Royal Philips announced a significant milestone in their collaboration with the treatment of the first...
Overlay Init